Header Logo

Connection

GLADSTONE AIREWELE to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications GLADSTONE AIREWELE has written about Antibodies, Monoclonal, Humanized.
GLADSTONE AIREWELE
Connection Strength
0.016
Antibodies, Monoclonal, Humanized
  1. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010 Jun; 11(6):543-52.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.